Medical Store Booked For Overpricing In Rewari

CHANDIGARH : A team of Food and Drug Administration on Sunday conducted a raid and seized medicines being sold at higher prices than MRP in Haryana’s Rewari district.

The raid was conducted on the instruction of the Haryana health and family welfare minister, Anil Vij.

Giving information in this regard, a spokesperson of the Food and Drug Administration said that acting on the tip-off, the Drug Control Officer, Rewari conducted a decoy operation at M/s Vinayak Medical Store where Sukhbir Singh, owner of the medical store was found selling cough syrup containing Codeine Phosphate at Rs 200 and capsule strip containing Tramadol Hydrochloride at Rs 100 without prescription by a registered pharmacist.

During the raid, Sukhbir could not produce the Retail Sale Drug License (RSDL) for the sale of these medicinal narcotic products, which he is selling at a higher price than the MRP. Notably, the MRP of the cough syrup is Rs 143 and the capsule strip is Rs 57.

The spokesman said that following the raid, 672 capsules containing tramadol and 7 syrups containing codeine phosphate were recovered. This medical store has been sealed and FIR against Sukhbir Singh and others under sections of NDPS Act and Essential Commodities Act 1955 and DPCO 2013 has been registered at police station, Kasola, Rewari.

He said that strict action will be taken against drug peddlers who indulged in such illicit practices.

  • Related Posts

    Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

    Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

    Aytu BioPharma launches depression drug EXXUA in U.S. market

    DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

    Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

    Aytu BioPharma launches depression drug EXXUA in U.S. market

    Aytu BioPharma launches depression drug EXXUA in U.S. market

    Delhi govt carries out 27 raids against fake medicine

    Delhi govt carries out 27 raids against fake medicine

    Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

    Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

    ITS in AMTZ, 70 Countries participated for Future of Health Technology

    ITS in AMTZ, 70 Countries participated for Future of Health Technology

    Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

    Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session